The clear, trustworthy guide to therapeutic peptides — what they are, what the science says, what the FDA says right now, and how to talk to a licensed provider. Educational only. Not medical advice.https://peptiblox.com/https://peptiblox.com/blog/are-glp1-peptides/https://peptiblox.com/blog/are-glp1-peptides/Semaglutide and tirzepatide are the most famous molecules in medicine right now — and they are peptides. Here is what that means, how they work, and how they differ, in plain English.Fri, 10 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/bpc-157-evidence/https://peptiblox.com/blog/bpc-157-evidence/BPC-157 is one of the most-discussed recovery peptides — and one of the least studied in humans. Here is the real evidence, the gaps, and its current regulatory status.Mon, 13 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/cjc-1295-evidence/https://peptiblox.com/blog/cjc-1295-evidence/CJC-1295 is a long-acting GHRH analog discussed for growth hormone support. Here is the real human trial evidence, the safety history, and its current regulatory status.Fri, 24 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/compounded-vs-brand-semaglutide-2026/https://peptiblox.com/blog/compounded-vs-brand-semaglutide-2026/Mass compounding of semaglutide mostly ended in 2025. Here is what is still legally compounded, how brand-name pricing has shifted, and how to tell the two apart in 2026.Mon, 13 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/fda-peptide-reclassification-2026/https://peptiblox.com/blog/fda-peptide-reclassification-2026/In 2026 the FDA moved 12 peptides — including BPC-157 and TB-500 — off its restricted list. Here is what changed, what did not, and what the July PCAC review means, in plain English.Sun, 12 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/glp-1-telehealth-cost-2026/https://peptiblox.com/blog/glp-1-telehealth-cost-2026/What semaglutide and tirzepatide actually cost via telehealth in 2026 — insured, manufacturer cash-pay programs, and bundled telehealth pricing — broken down plainly.Fri, 24 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/glp-1-telehealth-how-it-works/https://peptiblox.com/blog/glp-1-telehealth-how-it-works/How GLP-1 telehealth actually works in 2026 — the intake, the licensed prescriber, what gets shipped, and how it differs from a site that skips the exam entirely.Fri, 24 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/how-to-get-peptides-prescribed/https://peptiblox.com/blog/how-to-get-peptides-prescribed/A step-by-step, no-hype guide to accessing peptides the legal and safe way — through a licensed provider and a compounding pharmacy — plus what things cost and the red flags to avoid.Wed, 08 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/ipamorelin-evidence/https://peptiblox.com/blog/ipamorelin-evidence/Ipamorelin is a selective ghrelin receptor agonist discussed for growth hormone support. Here is what human research actually shows, the gaps, and its current regulatory status.Fri, 24 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/is-bpc-157-legal-in-2026/https://peptiblox.com/blog/is-bpc-157-legal-in-2026/BPC-157 is not FDA-approved and not banned outright. Here is its actual regulatory status in 2026, what changed in April, and and what the July 2026 PCAC vote means.Mon, 13 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/pcac-july-2026-review-explained/https://peptiblox.com/blog/pcac-july-2026-review-explained/On July 23–24, 2026 the FDA advisory committee weighs BPC-157, TB-500, MOTS-c, KPV, Semax, Epitalon, and DSIP. Here is what the meeting can and cannot change.Mon, 13 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/pcac-vote-bpc-157-tb-500-kpv-mots-c/https://peptiblox.com/blog/pcac-vote-bpc-157-tb-500-kpv-mots-c/In July 2026 an FDA advisory committee recommended 6 of 7 peptides, including BPC-157 and TB-500, for the 503A Bulks List. Here are the votes and what comes next.Fri, 24 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/retatrutide-triumph-2-results/https://peptiblox.com/blog/retatrutide-triumph-2-results/Full TRIUMPH-2 results for retatrutide in type 2 diabetes: up to 20.8% weight loss and A1C down up to 1.6 points at 80 weeks. What the numbers mean, plainly.Thu, 01 Oct 2026 00:00:00 GMThttps://peptiblox.com/blog/retatrutide-vs-tirzepatide-vs-semaglutide/https://peptiblox.com/blog/retatrutide-vs-tirzepatide-vs-semaglutide/Retatrutide, tirzepatide and semaglutide compared honestly: mechanism, trial weight loss, side effects, and the big difference: only two are FDA-approved today.Thu, 01 Oct 2026 00:00:00 GMThttps://peptiblox.com/blog/semaglutide-vs-tirzepatide/https://peptiblox.com/blog/semaglutide-vs-tirzepatide/Semaglutide vs tirzepatide, compared plainly: how they differ, what the trials show for weight loss, cost, side effects, and how to think about choosing — no hype.Mon, 13 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/tb-500-evidence/https://peptiblox.com/blog/tb-500-evidence/TB-500 is discussed as a synthetic version of thymosin beta-4. Here is what human and animal research actually show, the gaps, and its current regulatory status.Mon, 13 Jul 2026 00:00:00 GMThttps://peptiblox.com/blog/what-is-retatrutide/https://peptiblox.com/blog/what-is-retatrutide/Retatrutide is an investigational weekly injection that acts on three hormone receptors: GIP, GLP-1 and glucagon. How it works, what trials show, its status.Thu, 01 Oct 2026 00:00:00 GMThttps://peptiblox.com/blog/when-will-retatrutide-be-available/https://peptiblox.com/blog/when-will-retatrutide-be-available/Lilly plans to submit retatrutide to the FDA in Q1 2027. The realistic approval timeline, the early access program, and why "research" vials are not it.Thu, 01 Oct 2026 00:00:00 GMT